Inhaled antibiotics are used to respiratory tract infections. Patients are suffering from chronic respiratory diseases like cystic fibrosis (CF) and non-CF bronchiectasis may be affected complex infections, by Methicillin-resistant Staphylococcus aureus, and by Pseudomonas aeruginosa. Inhaled antibiotics have several advantages such as it can deliver high concentrations drug at place of infection without the systematic unfavorable effects. The main application of inhaled antibiotics is to enhance drug delivery to the target site of infection.
The rise in incidences of respiratory diseases such as asthma, COPD (Chronic obstructive pulmonary diseases), and bronchitis is expected to propel the global inhaled antibiotics market growth. For instance, as per the WHO report, 2020 asthma is common disease among children across the world and around 339 million people are suffering from asthma in 2016. Furthermore, as per the WHO data around 251 million cases of COPD were registered globally in 2016. Moreover,, rise in product launch activities as well as new product approvals will propel the global inhaled antibiotics market growth. For instance, in October 2017, Polyphor had launched an inhaled antibiotic murepavadin. It is type of outer membrane protein targeting antibiotic. It is specifically acts against the bacterial strain Pseudomonas aeruginosa. In addition to that, in February 2016 Teva Canada Limited had received approval from Health Canada for its generic solution called as PrTeva-Tobramycin Inhalation Solution. This solution used for the treatment of cystic fibrosis.
The side effects associated with drug inhalation and unattainability of single effective inhaler are some restraining factors which are expected to limit the global inhaled antibiotics market growth. Cough, wheezing, hemoptysis and dyspnea are most common side effects caused by inhaled antibiotics.
Global Inhaled Antibiotics Market is segmented into product type Aerosol, Dry Powder Formulation, and Spray, by application such as Pneumonia, Asthma, Bronchitis, and Others. Further, market is segmented into distribution channel such as Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies.
Also, Global Inhaled Antibiotics Market is segmented five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are listed in this report such as Lupin Ltd, Polyphor, Aradigm, Gilead Sciences, Insmed Incorporated, Pharmaero, Joincare Pharmaceutical Group, Savara Pharmaceuticals,and Pharmaxis Ltd
By Application Pneumonia Asthma Bronchitis Others
By Distribution Channel Retail Pharmacies Hospital Pharmacies Online Pharmacies
By Region North America Latin America Europe Asia Pacific Middle East & Africa
Key Questions Addressed by the Report What are the Key Opportunities in Global Inhaled Antibiotics Market? What will be the growth rate from 2019 to 2030? Which segment/region will have highest growth? What are the factors that will impact/drive the Market? What is the competitive Landscape in the Industry? What is the role of key players in the value chain? What are the strategies adopted by key players?
Global Inhaled Antibiotics Market TOC
1 Introduction 1.1 Objective of the Study 1.2 Market definition 1.3 Market Scope
2 Research Methodology
2.1 Data Mining 2.2 Validation 2.3 Primary Interviews 2.4 List of Data Sources
3 Executive Summary 4 Global Inhaled Antibiotics Market Outlook 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis
5 Global Inhaled Antibiotics Market, By Product Type 5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Inhaled Antibiotics Market Share Analysis, By Product Type
5.3 Global Inhaled Antibiotics Market Size and Forecast, By Product Type 5.3.1 Aerosol
5.3.2. Dry Powder Formulation
5.3.3 Spray
6 Global Inhaled Antibiotics Market, By Application 6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Inhaled Antibiotics Market Share Analysis, By Application
6.3 Global Inhaled Antibiotics Market Size and Forecast, By Application 6.3.1Pneumonia
6.3.2 Asthma
6.3.3 Bronchitis
6.3.4 Others
7 Global Inhaled Antibiotics Market, By Distribution Channel 7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Inhaled Antibiotics Market Share Analysis, By Distribution Channel
7.3 Global Inhaled Antibiotics Market Size and Forecast, By Distribution Channel 7.3. 1 Retail Pharmacies
7.3.2. Hospital Pharmacies
7.3.3. Online Pharmacies
8Global Inhaled Antibiotics Market, By Region 8.1 Global Inhaled Antibiotics Market Share Analysis, By Region
8.2 Global Inhaled Antibiotics Market Share Analysis, By Region
8.3 Global Inhaled Antibiotics Market Size and Forecast, By Region
9 North America Inhaled Antibiotics Market Analysis and Forecast (2020-2027) 9.1 Introduction
9.2 North America Inhaled Antibiotics Market Share Analysis, By Product Type
9.3 North America Inhaled Antibiotics Market Size and Forecast, By Application
9.4 North America Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
9.5 North America Inhaled Antibiotics Market Size and Forecast, By Country
9.5.1 U.S. 9.5.2 Canada 9.5.3 Mexico
10EuropeInhaled Antibiotics Market Analysis and Forecast (2020-2027) 10.1 Introduction
10.2 Europe Inhaled Antibiotics Market Share Analysis, By Product Type
10.3 Europe Inhaled Antibiotics Market Size and Forecast, By Application
10.4 Europe Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
10.5 Europe Inhaled Antibiotics Market Size and Forecast, By Country
10.5.1 Germany 10.5.2 France 10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Inhaled Antibiotics Market Analysis and Forecast (2020-2030) 11.1 Introduction
11.2 Asia Pacific Inhaled Antibiotics Market Share Analysis, By Product Type
11.3 Asia Pacific Inhaled Antibiotics Market Size and Forecast, By Application
11.4 Asia Pacific Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Inhaled Antibiotics Market Size and Forecast, By Country
11.5.1 China 11.5.2 Japan 11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Inhaled Antibiotics Market Analysis and Forecast (2020-2030) 12.1 Introduction
12.2 Latin America Inhaled Antibiotics Market Share Analysis, By Product Type
12.3 Latin America Inhaled Antibiotics Market Size and Forecast, By Application
12.4 Latin America Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
12.5 Latin America Inhaled Antibiotics Market Size and Forecast, Country
13Middle East Inhaled Antibiotics Market Analysis and Forecast (2020-2030) 13.1 Introduction
13.2 Middle East Inhaled Antibiotics Market Share Analysis, By Product Type
13.3 Middle East Inhaled Antibiotics Market Size and Forecast, By Application
13.4 Middle East Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
13.5 Middle East Inhaled Antibiotics Market Size and Forecast, By Country
14Competitive Analysis 14.1 Competition Dashboard 14.2 Market share Analysis of Top Vendors 14.3 Key Development Strategies
15Company Profiles
15.1 Lupin Ltd
15.1.1 Overview 15.1.2 Offerings 15.1.3 Key Financials 15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2.Polyphor
15.2.1 Overview 15.2.2 Offerings 15.2.3 Key Financials 15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Aradigm
15.3.1 Overview 15.3.2 Offerings 15.3.3 Key Financials 15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Gilead Sciences
15.4.1 Overview 15.4.2 Offerings 15.4.3 Key Financials 15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Insmed Incorporated
15.5.1 Overview 15.5.2 Offerings 15.5.3 Key Financials 15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Pharmaero 15.6.1 Overview 15.6.2 Offerings 15.6.3 Key Financials 15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Joincare Pharmaceutical Group
15.7.1 Overview 15.7.2 Offerings 15.7.3 Key Financials 15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Savara Pharmaceuticals
15.8.1 Overview 15.8.2 Offerings 15.8.3 Key Financials 15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Pharmaxis Ltd
15.9.1 Overview 15.9.2 Offerings 15.9.3 Key Financials 15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
